Next Day Disclosure Returns
Filed with HKEX · Stock code 2256 · · 7 pages · English
Earlier from Abbisko Cayman
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim report
- Voluntary announcement - abbisko therapeutics announces positive preliminary phase II results with lavengratinib (ABSK061) for the treatment of achondroplasia
- Poll results of the extraordinary general meeting held on September 17, 2026
Later from Abbisko Cayman
All Abbisko Cayman news releasesFollow Abbisko Cayman into a list and get an email when it puts out news.
Follow Abbisko Cayman